Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration

NCT04026256 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04026256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04026256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanisms Underlying the Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 2, 2019
Completion date
April 18, 2022
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postmenopausal osteoporosis